135 related articles for article (PubMed ID: 10972897)
21. Rational design and purification of human Bruton's tyrosine kinase SH3-SH2 protein for structure-function studies.
Nera KP; Brockmann E; Vihinen M; Smith CI; Mattsson PT
Protein Expr Purif; 2000 Dec; 20(3):365-71. PubMed ID: 11087675
[TBL] [Abstract][Full Text] [Related]
22. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase.
Noack D; Rae J; Cross AR; Muñoz J; Salmen S; Mendoza JA; Rossi N; Curnutte JT; Heyworth PG
Hum Genet; 1999 Nov; 105(5):460-7. PubMed ID: 10598813
[TBL] [Abstract][Full Text] [Related]
23. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease.
Tsuda M; Kaneda M; Sakiyama T; Inana I; Owada M; Kiryu C; Shiraishi T; Kakinuma K
Hum Genet; 1998 Oct; 103(4):377-81. PubMed ID: 9856476
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
[TBL] [Abstract][Full Text] [Related]
25. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
[TBL] [Abstract][Full Text] [Related]
26. Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase.
Vargas-Hernández A; López-Herrera G; Maravillas-Montero JL; Vences-Catalán F; Mogica-Martínez D; Rojo-Domínguez A; Espinosa-Rosales FJ; Santos-Argumedo L
IUBMB Life; 2012 Apr; 64(4):346-53. PubMed ID: 22378381
[TBL] [Abstract][Full Text] [Related]
27. [Flow cytometry in the diagnosis of the primary immunodeficiencies].
García Rodríguez MC; Cambronero Martínez R; Ferreira Cerdán A; Fontán Casariego G
Sangre (Barc); 1999 Apr; 44(2):127-33. PubMed ID: 10382322
[No Abstract] [Full Text] [Related]
28. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Brandau O; Brandén LJ; Kwan SP; Lappalainen I; Lester T; Noordzij JG; Ochs HD; Ollila J; Pienaar SM; Riikonen P; Saha BK; Smith CI
Nucleic Acids Res; 1998 Jan; 26(1):242-7. PubMed ID: 9399844
[TBL] [Abstract][Full Text] [Related]
29. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
Hyvönen M; Saraste M
EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
[TBL] [Abstract][Full Text] [Related]
30. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
[TBL] [Abstract][Full Text] [Related]
31. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia.
Vihinen M; Zvelebil MJ; Zhu Q; Brooimans RA; Ochs HD; Zegers BJ; Nilsson L; Waterfield MD; Smith CI
Biochemistry; 1995 Feb; 34(5):1475-81. PubMed ID: 7849006
[TBL] [Abstract][Full Text] [Related]
33. A novel H(+) conductance in eosinophils: unique characteristics and absence in chronic granulomatous disease.
Bánfi B; Schrenzel J; Nüsse O; Lew DP; Ligeti E; Krause KH; Demaurex N
J Exp Med; 1999 Jul; 190(2):183-94. PubMed ID: 10432282
[TBL] [Abstract][Full Text] [Related]
34. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW
Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
[TBL] [Abstract][Full Text] [Related]
36. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
Mattsson PT; Vihinen M; Smith CI
Bioessays; 1996 Oct; 18(10):825-34. PubMed ID: 8885720
[TBL] [Abstract][Full Text] [Related]
37. An unusual intronic mutation in the CYBB gene giving rise to chronic granulomatous disease.
Noack D; Heyworth PG; Newburger PE; Cross AR
Biochim Biophys Acta; 2001 Sep; 1537(2):125-31. PubMed ID: 11566256
[TBL] [Abstract][Full Text] [Related]
38. BTKbase: a database of XLA-causing mutations. International Study Group.
Vihinen M; Cooper MD; de Saint Basile G; Fischer A; Good RA; Hendriks RW; Kinnon C; Kwan SP; Litman GW; Notarangelo LD
Immunol Today; 1995 Oct; 16(10):460-5. PubMed ID: 7576047
[No Abstract] [Full Text] [Related]
39. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
Petro JB; Rahman SM; Ballard DW; Khan WN
J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
[TBL] [Abstract][Full Text] [Related]
40. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
